HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy

AIDS

Volumn 26, Issue 7, 2012, Pages 843-853

  Hearps, Anna C ^a,b   Maisa, Anna ^a   Cheng, Wan Jung ^a   Angelovich, Thomas A ^a,c   Lichtfuss, Gregor F ^a,b   Palmer, Clovis S ^a,d   Landay, Alan L ^e   Jaworowski, Anthony ^a,b   Crowe, Suzanne M ^a,b,f  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c RMIT UNIVERSITY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f ALFRED HOSPITAL   (Australia)

Author keywords

combination antiretroviral therapy; HIV; immune activation; innate immunity; monocyte; telomere length

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL MARKER; CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; L SELECTIN; NEOPTERIN; TOLL LIKE RECEPTOR 4;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL AGING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOASSAY; INNATE IMMUNITY; MALE; MONOCYTE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; VIREMIA; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MONOCYTES;

EID: 84859938086     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328351f756     Document Type: Article

References (65)

1. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr 2009; 51:268-273.
2. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007; 62:1279-1286. (Pubitemid 350287617)
3. Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld C, et al. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med 2007; 167:2213-2219. (Pubitemid 350106741)
4. Ozdener H. Molecular mechanisms of HIV-1 associated neurodegeneration. J Biosci 2005; 30:391-405. (Pubitemid 40992220)
5. Effros RB. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev Comp Immunol 1997; 21:471-478. (Pubitemid 28030860)
6. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, et al. Inflammaging and antiinflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007; 128:92-105. (Pubitemid 46073065)
7. Ostan R, Bucci L, Capri M, Salvioli S, Scurti M, Pini E, et al. Immunosenescence and immunogenetics of human longevity. Neuroimmunomodulation 2008; 15:224-240.
8. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106:506-512. (Pubitemid 29231100)
9. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80:219-227.
10. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008; 5:e78.
11. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002; 50:1268-1271. (Pubitemid 34774552)
12. Jenny NS, Tracy RP, Ogg MS, Luong le A, Kuller LH, Arnold AM, et al. In the elderly, interleukin-6 plasma levels and the-174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 2002; 22:2066-2071. (Pubitemid 36025216)
13. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 2008; 214:231-241. (Pubitemid 351160160)
14. Effros RB, Allsopp R, Chiu CP, Hausner MA, Hirji K, Wang L, et al. Shortened telomeres in the expanded CD28-CD8R cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996; 10:F17-22. (Pubitemid 26229506)
15. Cao W, Jamieson BD, Hultin LE, Hultin PM, Effros RB, Detels R. Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr 2009; 50:137-147.
16. Derhovanessian E, Larbi A, Pawelec G. Biomarkers of human immunosenescence: impact of cytomegalovirus infection. Curr Opin Immunol 2009; 21:440-445.
17. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009; 19:47-56.
18. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371. (Pubitemid 44924494)
19. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009; 17:118-123.
20. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, Jacobson LP, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859-870. (Pubitemid 29159331)
21. Jiang W, Lederman MM, Hunt P, Sieg SF, Haley K, Rodriguez B, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:1177-1185.
22. Rajasuriar R, Booth D, Solomon A, Chua K, Spelman T, Gouillou M, et al. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor alpha and microbial translocation. J Infect Dis 2010; 202:1254-1264.
23. Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, et al. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after antiretroviral therapy. J Infect Dis 2011; 204:154-163.
24. Sandler NG, Wand H, Roque A, Law M, Nason MC, Nixon DE, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis 2011; 203:780-790.
25. Burdo TH, Lo J, Abbara S, Wei J, Delelys ME, Preffer F, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011; 204:1227-1236.
26. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168:4531-4537. (Pubitemid 34441357)
27. Gerrity RG, Naito HK. Ultrastructural identification of monocyte-derived foam cells in fatty streak lesions. Artery 1980; 8:208-214. (Pubitemid 11154651)
28. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Unique monocyte subset in patients with AIDS dementia. Lancet 1997; 349:692-695. (Pubitemid 27107748)
29. Schmid I, Jamieson BD. Assessment of telomere length, phenotype, and DNA content. Curr Protoc Cytom 2004,Chapter 7:Unit 7 26. pp. 1-13
30. Larsson I, Lundgren E, Nilsson K, Strannegard O. A human neoplastic hematopoietic cell line producing a fibroblast type of interferon. Dev Biol Stand 1979; 42:193-197. (Pubitemid 9138926)
31. Tippett E, Cheng WJ, Westhorpe C, Cameron PU, Brew BJ, Lewin SR, et al. Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals. PLoS One 2011; 6:e19968.
32. Lundahl J, Hallden G, Hallgren M, Skold CM, Hed J. Altered expression of CD11b/CD18 and CD62L on human monocytes after cell preparation procedures. J Immunol Methods 1995; 180:93-100.
33. Wolthers KC, Bea G, Wisman A, Otto SA, de Roda Husman AM, Schaft N, et al. T cell telomere length in HIV-1 infection: no evidence for increased CD4R T cell turnover. Science 1996; 274:1543-1547. (Pubitemid 26403933)
34. Palmer LD, Weng N, Levine BL, June CH, Lane HC, Hodes RJ. Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4R and CD8R T cells from HIV-discordant monozygotic twins. J Exp Med 1997; 185:1381-1386. (Pubitemid 27172918)
35. Pommier JP, Gauthier L, Livartowski J, Galanaud P, Boue F, Dulioust A, et al. Immunosenescence in HIV pathogenesis. Virology 1997; 231:148-154. (Pubitemid 27238773)
36. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14RCD16R DRRR monocytes are a major source of TNF. J Immunol 2002; 168:3536-3542. (Pubitemid 34250422)
37. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW. The novel subset of CD14R/CD16R blood monocytes is expanded in sepsis patients. Blood 1993; 82:3170-3176. (Pubitemid 23334947)
38. Nockher WA, Scherberich JE. Expanded CD14RCD16Rmonocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998; 66:2782-2790. (Pubitemid 28261784)
39. Heron M, Grutters JC, van Velzen-Blad H, Veltkamp M, Claessen AM, van den Bosch JM. Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis. Chest 2008; 134:1001-1008.
40. Nyugen J, Agrawal S, Gollapudi S, Gupta S. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol 2010; 30:806-813.
41. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 1995; 25:3418-3424.
42. Jaworowski A, Ellery P, Maslin CL, Naim E, Heinlein AC, Ryan CE, et al. Normal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patients. J Infect Dis 2006; 193:693-697. (Pubitemid 43273494)
43. Weiner LM, Li W, Holmes M, Catalano RB, Dovnarsky M, Padavic K, et al. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 1994; 54:4084-4090. (Pubitemid 24258113)
44. Sotiriou SN, Orlova VV, Al-Fakhri N, Ihanus E, Economopoulou M, Isermann B, et al. Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin. FASEB J 2006; 20:559-561. (Pubitemid 46671249)
45. van Royen N, Hoefer I, Bottinger M, Hua J, Grundmann S, Voskuil M, et al. Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ Res 2003; 92:218-225. (Pubitemid 36254278)
46. Griffin JD, Spertini O, Ernst TJ, Belvin MP, Levine HB, Kanakura Y, et al. Granulocyte-macrophage colony-stimulating factor and other cytokines regulate surface expression of the leukocyte adhesion molecule-1 on human neutrophils, monocytes, and their precursors. J Immunol 1990; 145:576-584. (Pubitemid 20252365)
47. Trial J, Birdsall HH, Hallum JA, Crane ML, Rodriguez-Barradas MC, de Jong AL, et al. Phenotypic and functional changes in peripheral blood monocytes during progression of human immunodeficiency virus infection. Effects of soluble immune complexes, cytokines, subcellular particulates from apoptotic cells, and HIV-1-encoded proteins on monocytes phagocytic function, oxidative burst, transendothelial migration, and cell surface phenotype. J Clin Invest 1995; 95:1690-1701.
48. Rossen RD, Smith CW, Laughter AH, Noonan CA, Anderson DC, McShan WM, et al. HIV-1-stimulated expression of CD11/CD18 integrins and ICAM-1: a possible mechanism for extravascular dissemination of HIV-1-infected cells. Trans Assoc Am Physicians 1989; 102:117-130.
49. Li W, Stanley ER. Role of dimerization and modification of the CSF-1 receptor in its activation and internalization during the CSF-1 response. EMBO J 1991; 10:277-288. (Pubitemid 21905477)
50. Chen BD, Chou TH, Sensenbrenner L. Downregulation of M-CSF receptors by lipopolysaccharide in murine peritoneal exudate macrophages is mediated through a phospholipase C dependent pathway. Exp Hematol 1993; 21:623-628. (Pubitemid 24212362)
51. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008; 181:3733-3739.
52. Lambin P, Desjobert H, Debbia M, Fine JM, Muller JY. Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors. Lancet 1986; 2:1216. (Pubitemid 17204890)
53. Stylianou E, Aukrust P, Bendtzen K, Muller F, Froland SS. Interferons and interferon (IFN)-inducible protein 10 during highly active antiretroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection. Clin Exp Immunol 2000; 119:479-485. (Pubitemid 30146344)
54. Leng SX, Tian X, Matteini A, Li H, Hughes J, Jain A, et al. IL-6-independent association of elevated serum neopterin levels with prevalent frailty in community-dwelling older adults. Age Ageing 2011; 40:475-481.
55. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002; 3:175-187. (Pubitemid 34326529)
56. Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, et al. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 2006; 113:2301-2312. (Pubitemid 43947976)
57. Fuchs D, Moller AA, Reibnegger G, Stockle E, Werner ER, Wachter H. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. J Acquir Immune Defic Syndr 1990; 3:873-876. (Pubitemid 20330669)
58. Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, et al. Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection. J Neuroimmunol 2005; 168:154-163. (Pubitemid 41396413)
59. Kolb SA, Sporer B, Lahrtz F, Koedel U, Pfister HW, Fontana A. Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol 1999; 93:172-181. (Pubitemid 29051563)
60. Luster AD, Unkeless JC, Ravetch JV. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985; 315:672-676. (Pubitemid 15232881)
61. Burdo TH, Soulas C, Orzechowski K, Button J, Krishnan A, Sugimoto C, et al. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 2010; 6:e1000842.
62. Vignoli M, Stecca B, Furlini G, Re MC, Mantovani V, Zauli G, et al. Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients. AIDS 1998; 12:999-1005. (Pubitemid 28276966)
63. Calado RT, Young NS. Telomere diseases. N Engl J Med 2009; 361:2353-2365.
64. Kedzierska K, Mak J, Mijch A, Cooke I, Rainbird M, Roberts S, et al. Granulocyte-macrophage colony-stimulating factor augments phagocytosis of Mycobacterium avium complex by human immunodeficiency virus type 1-infected monocytes/macrophages in vitro and in vivo. J Infect Dis 2000; 181:390-394. (Pubitemid 30049077)
65. Crowe SM, Vardaxis NJ, Kent SJ, Maerz AL, Hewish MJ, McGrath MS, et al. HIV infection of monocyte-derived macrophages in vitro reduces phagocytosis of Candida albicans. J Leukoc Biol 1994; 56:318-327. (Pubitemid 24295800)